Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.49), $0.10 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• VNET Group Q2 2026 revenue rises 14.2% on wholesale growth
• Tesla to launch Cybercab in Austin this month - report